Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
Phase
2Span
177 weeksSponsor
Kowa Research Institute, Inc.Takasaki, Gunma
Recruiting
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
Phase
3Span
494 weeksSponsor
Eli Lilly and CompanyTakasaki, Gunma
Recruiting
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
Phase
3Span
496 weeksSponsor
Eli Lilly and CompanyTakasaki, Gunma
Recruiting
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Phase
3Span
219 weeksSponsor
Hoffmann-La RocheTakasaki
Recruiting
A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis
Phase
2Span
74 weeksSponsor
Ono Pharmaceutical Co. LtdTakasaki, Gunma
Recruiting
Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings
Phase
N/ASpan
153 weeksSponsor
Ferring PharmaceuticalsTakasaki, Gunma
Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Phase
3Span
236 weeksSponsor
Boehringer IngelheimTakasaki
Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Phase
3Span
376 weeksSponsor
Boehringer IngelheimTakasaki
Recruiting
1-8 of 8